Skip to main content

Table 4 Comparison of numbers of IOP-lowering medications according to occurrence of early hypertensive phase

From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant

 

EHP (−) group (n = 15)

EHP (+) group (n = 5)

p-value

Month 1

0.8 ± 1.1

3.4 ± 0.5

0.001a

Month 2

1.0 ± 1.1

3.6 ± 0.5

0.001a

Month 3

1.2 ± 1.2

3.8 ± 0.4

0.000a

Month 6

1.3 ± 1.3

3.8 ± 0.4

0.002a

Year 1

1.3 ± 1.3

3.8 ± 0.4

0.005a

  1. aMann-Whitney U-test; IOP intraocular pressure, EHP early hypertensive phase
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us